Blockade of ALDH in Cisplatin-Resistant Ovarian Cancer Stem Cells In Vitro Synergistically Enhances Chemotherapy-Induced Cell Death
Epithelial ovarian cancer (EOC) is the leading cause of gynecological cancer-related death. The high mortality and morbidity associated with EOC are mostly due to late diagnosis and chemotherapy drug resistance. Currently, the standard first-line chemotherapy regimen is systemic administration of pl...
Main Authors: | Guo, F. (Author), Kaufmann, A.M (Author), Sehouli, J. (Author), Yang, Z. (Author) |
---|---|
Format: | Article |
Language: | English |
Published: |
NLM (Medline)
2022
|
Subjects: | |
Online Access: | View Fulltext in Publisher |
Similar Items
-
Inhibitory effect on ovarian cancer ALDH+ stem-like cells by Disulfiram and Copper treatment through ALDH and ROS modulation
by: Fang Guo, et al.
Published: (2019-10-01) -
Disulfiram modulates ROS accumulation and overcomes synergistically cisplatin resistance in breast cancer cell lines
by: Zhi Yang, et al.
Published: (2019-05-01) -
The Role of Adjuvant Chemotherapy in Operable Non-small Cell Lung Cancer
by: Xiangtao YAN, et al.
Published: (2011-03-01) -
Feasibility and Safety of Perioperative Chemotherapy With Fluorouracil Plus Leucovorin, Oxaliplatin, and Docetaxel for Locally Advanced Gastric Cancer Patients in China
by: Birendra Kumar Sah, et al.
Published: (2021-01-01) -
Synergistic Antitumor Effect of Oligogalacturonides and Cisplatin on Human Lung Cancer A549 Cells
by: Cian-Song Huang, et al.
Published: (2018-06-01)